Pharmacopuncture for stroke survivors: A systematic review of randomized controlled trials in South Korea

Kim, Mi-Kyung; Han, Chang-ho

doi:10.1016/j.ctcp.2020.101179

Cited by 10 publications

(7 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Following cerebrovascular incidents, central poststroke pain often manifests as sensory disturbances and neuropathic pain [ 76 ]. Pharmacopuncture is a widely used intervention for poststroke pain [ 77 ]. In a single-blind randomized controlled clinical trial, they recruited 20 patients who were suffering from central poststroke pain.…”

Section: Clinical Applications and Mechanism Of Bv Injectionmentioning

confidence: 99%

Clinical Applications of Bee Venom Acupoint Injection

Lin

Hsieh

2020

Toxins

View full text Add to dashboard Cite

Bee venom is a complex natural mixture with various pharmaceutical properties. Among these properties, its peptides and enzymes have potential medical therapy for pain relief and inflammation. In clinical settings, this therapy has been used widely to treat diseases by injecting into acupoints. In this article, we have conducted various research from PubMed, Cochrane Library, and Clinical Key from inception of July 2020. The results revealed that bee venom therapy has been reported effective in anti-inflammatory, antiapoptosis, and analgesic effects. Moreover, bee venom acupuncture has been commonly used for clinical disorders such as Parkinson disease, neuropathic pain, Alzheimer disease, intervertebral disc disease, spinal cord injury, musculoskeletal pain, arthritis, multiple sclerosis, skin disease and cancer.

show abstract

Section: Clinical Applications and Mechanism Of Bv Injectionmentioning

confidence: 99%

Clinical Applications of Bee Venom Acupoint Injection

Lin

Hsieh

2020

Toxins

View full text Add to dashboard Cite

show abstract

“…Currently, pharmacopuncture is applied for various diseases and has shown excellent efficacy to treat musculoskeletal disorders and obesity [41]. Moreover, it has been used to alleviate symptoms in patients with cancer and stroke [42,43], as well as to treat peripheral neuropathy [44] and asthma [45]. Additionally, several studies have confirmed its safety [46,47].…”

Section: Discussionmentioning

confidence: 99%

Long-Term Follow-Up of Inpatients with Failed Back Surgery Syndrome Who Received Integrative Korean Medicine Treatment: A Retrospective Analysis and Questionnaire Survey Study

Park

Choi

Kim

et al. 2021

JCM

View full text Add to dashboard Cite

Introduction: this study aimed to investigate the long-term clinical efficacy and satisfaction degree of integrative Korean medicine (KM) treatment for patients with failed back surgery syndrome (FBSS). Methods: we performed a follow-up questionnaire survey and retrospective analysis of medical records for patients with FBSS who underwent inpatient treatment for ≥ 1 week. The primary evaluation indices were numeric rating scale (NRS) scores for low back pain (LBP) and leg pain at admission and discharge. Sub-evaluation indices included the Oswestry Disability Index (ODI) and EuroQol 5-dimension (EQ-5D) score. The follow-up questionnaire survey obtained information regarding previous surgeries; reasons for satisfaction/dissatisfaction with surgical and KM treatment; and current status. Results: compared with at admission, there was a significant post-treatment decrease in the NRS scores for LBP and leg pain, as well as the ODI score. Further, there was a significant post-treatment increase in the EQ-5D score. Regarding the patients’ global impression of change for KM treatment administered during admission and at the follow-up questionnaire survey, 101 (95.3%) patients selected “minimally improved” or better. Conclusion: integrative KM treatment could effectively reduce pain, as well as improve function and health-related quality of life, in patients with FBSS.

show abstract

“…Compared with traditional acupuncture, PA has a rapid therapeutic effect, combines the synergistic effects of biochemical herbal components and the physical stimulation of acupoints, and easy dosage control [ 12 - 14 ]. Although PA is primarily utilized for musculoskeletal diseases, research suggests it may be used to treat idiopathic Parkinson’s disease, asthma, cancer, and post-stroke management [ 15 - 19 ].…”

Section: Introductionmentioning

confidence: 99%

Pharmacoacupuncture for the Treatment of Frozen Shoulder: protocol for a systematic review and meta-analysis

Lee,

Park,

Park

et al. 2024

J Pharmacopuncture

View full text Add to dashboard Cite

Objectives Frozen shoulder (FS) is one of the most challenging shoulder disorders for patients and clinicians. Its symptoms mainly include any combination of stiffness, nocturnal pain, and limitation of active and passive glenohumeral joint movement. Conventional treatment options for FS are physical therapy, nonsteroidal anti-inflammatory drugs, injection therapy, and arthroscopic capsular release, but adverse and limited effects continue to present problems. As a result, pharmacoacupuncture (PA) is getting attention as an alternative therapy for patients with FS. PA is a new form of acupuncture treatment in traditional Korean medicine (TKM) that is mainly used for musculoskeletal diseases. It has similarity and specificity compared to corticosteroid injection and hydrodilatation, making it a potential alternative injection therapy for FS. However, no systematic reviews investigating the utilization of PA for FS have been published. Therefore, this review aims to standardize the clinical use of PA for FS and validate its therapeutic effect. Methods The protocol was registered in Prospero (CRD42023445708) on 18 July 2023. Until Aug. 31, 2023, seven electronic databases will be searched for randomized controlled trials of PA for FS. Authors will be contacted, and manual searches will also be performed. Two reviewers will independently screen and collect data from retrieved articles according to predefined criteria. The primary outcome will be pain intensity, and secondary outcomes will be effective rate, Constant-Murley Score, Shoulder Pain and Disability Index, range of motion, quality of life, and adverse events. Bias and quality of the included trials will be assessed using the Cochrane handbook’s risk-of-bias tool for randomized trials. Meta analyses will be conducted using Review Manager V.5.3 software. GRADE will be used to evaluate the level of evidence for each outcome. Results This systematic review and meta-analysis will be conducted following PRISMA statement. The results will be published in a peer-reviewed journal. Conclusion This review will provide scientific evidence to support health insurance policy as well as the standardization of PA in clinical practice.

show abstract

Pharmacopuncture for stroke survivors: A systematic review of randomized controlled trials in South Korea

Cited by 10 publications

References 26 publications

Clinical Applications of Bee Venom Acupoint Injection

Clinical Applications of Bee Venom Acupoint Injection

Long-Term Follow-Up of Inpatients with Failed Back Surgery Syndrome Who Received Integrative Korean Medicine Treatment: A Retrospective Analysis and Questionnaire Survey Study

Pharmacoacupuncture for the Treatment of Frozen Shoulder: protocol for a systematic review and meta-analysis

Contact Info

Product

Resources

About